<p>Will decentralized clinical trials continue to be a hot topic even after the pandemic or will pharma companies revert to their old ways. Our guest, <a href='http://clinicalleader.com/'>ClinicalLeader.com</a> Chief Editor, Ed Miseta, weighs in on this timely topic.</p>

Will decentralized clinical trials continue to be a hot topic even after the pandemic or will pharma companies revert to their old ways. Our guest, ClinicalLeader.com Chief Editor, Ed Miseta, weighs in on this timely topic.

<p>Will decentralized clinical trials continue to be a hot topic even after the pandemic or will pharma companies revert to their old ways. Our guest, <a href="http://clinicalleader.com/" rel="noopener noreferrer">ClinicalLeader.com</a>&nbsp;Chief Editor, Ed Miseta, weighs in on this timely topic.</p>

025: Are Decentralized Trials Finally Here To Stay?

Life Science Connect Editorial Director, Dan Schell, works with a talented and passionate group of editors. Each week, he sits down with them to discuss their pressing coverage areas, latest travels, and interesting interviews from within the life sciences landscape. His rotating cast of contributors includes Life Science Connect editors Rob Wright, Ed Miseta, Louis Garguilo, Anna Rose Welch, Erin Harris, and Matt Pillar.

Share 025: Are Decentralized Trials Finally Here To Stay?

Sign up to save your podcasts

025: Are Decentralized Trials Finally Here To Stay?

025: Are Decentralized Trials Finally Here To Stay?